Quantcast
Last updated on April 19, 2014 at 6:57 EDT

Latest Crohn's disease Stories

2013-10-29 23:28:47

A new report and video from Health News Wires titled Specific Digestive Disorders Linked to Increase in Heart Attacks details how certain digestive disorders increase the risk of heart attack and stroke. Boston, MA (PRWEB) October 29, 2013 A new report and video from Health News Wires titled Specific Digestive Disorders Linked to Increase in Heart Attacks details how certain digestive disorders increase the risk of heart attack and stroke. People suffering from inflammatory bowel disease,...

Sweet Tooth In Gut Bacteria Helps Keep Us Healthy
2013-10-27 05:07:45

redOrbit Staff & Wire Reports - Your Universe Online It may not be good for your health if you have too much of a “sweet tooth,” but it’s an entirely different story when it comes to some strains of gut bacteria, according to new research appearing in Friday’s edition of the open-access, peer reviewed scientific journal PLoS ONE. Researchers from the Institute of Food Research looked at the interaction between those bacteria, which help us digest the food that we eat and...

2013-10-24 10:16:46

A drug currently on the market to treat leukemia reversed symptoms of colitis in lab tests, according to recently published findings by medical researchers with the University of Alberta. Faculty of Medicine & Dentistry researcher Shairaz Baksh published his team's discovery in the peer-reviewed journal, PLOS ONE. His team discovered that a tumour-suppressor gene can also play an important role in the development of colitis. When this gene quits working or is missing, the...

2013-10-03 08:57:15

Researchers discover that the cells play a major role in inflammation which underlies Crohn's disease in small intestine Scientists have discovered that Crohn's disease, the inflammatory bowel disorder, can originate from specialized intestinal cell type called Paneth cells. As such, they propose that small intestinal Crohn's disease might be a specific disorder of this cell type, providing a possible new target for treatments. The study, by researchers from the University of Cambridge and...

2013-10-01 23:04:08

HB 1183, which passed the General Assembly and was signed into law by Governor Martin O’Malley on April 18, 2013 expands access to an “employee only” bathroom in retail establishments for Ostomy patients as well as individuals suffering from Crohn’s Disease, Ulcerative Colitis, and other medical conditions that require immediate access to a restroom, when no public restroom facilities are otherwise available. Rockville, MD (PRWEB) October 01, 2013 Metro Maryland Ostomy...

Mucus Protects Gut
2013-09-27 13:23:45

Michael Harper for redOrbit.com - Your Universe Online Researchers from the Icahn School of Medicine at Mount Sinai’s Immunology Institute say they’ve discovered an important role played by mucus in the gut. Though little was previously known about mucus, the Icahn doctors say the slimy, sticky stuff acts as an anti-inflammatory in the stomach and provides a protective self-regulating immune function. The research also showed that mucus acts as a protective barrier against bacteria...

2013-09-26 23:23:44

Mount Sinai Researchers Discover Mucus Prevents Inflammatory Reactions in the Gut New York, NY (PRWEB) September 26, 2013 Imagine mucus – which most people find unpleasant – actually helping your body maintain its equilibrium, prevent inflammation, and reduce food allergy problems. Researchers from the Icahn School of Medicine at Mount Sinai’s Immunology Institute foresee a day when mucus could be manufactured and given to sick people to help them fight inflammation and increase...

2013-09-24 23:19:33

Reportbuyer.com just published a new market research report: Inflammatory Bowel Diseases: World Drug Market 2013-2023. London (PRWEB) September 24, 2013 Report Details Medicines for bowel inflammation - you explore R&D and potential sales What's the future for treating inflammatory bowel diseases (IBD)? Visiongain's updated report gives you revenue predictions from 2013, helping you stay ahead. There you find financial results, R&D trends, opportunities, and potential...

2013-09-10 08:28:41

European Commission approval is a significant milestone for availability of lower-cost biologic therapy LEAMINGTON SPA, England, Sept. 10, 2013 /PRNewswire/ -- Hospira (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today announced the European Commission (EC) approval of Inflectra(TM) (infliximab), Europe's first biosimilar monoclonal antibody (mAb) therapy. Inflectra has been approved for the treatment of inflammatory conditions including rheumatoid...

2013-09-04 12:34:08

DEERFIELD, Ill. and OSAKA, Japan, Sept. 4, 2013 /PRNewswire/ -- Takeda Pharmaceutical Company Limited ("Takeda") and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., today announced that the United States (U.S.) Food and Drug Administration (FDA) has granted Priority Review status for the Biologics License Application (BLA) for its new investigational drug vedolizumab for the treatment of adults with moderately to severely active ulcerative colitis. A BLA was...